As well as US tax plans and yet more on Brexit, it promises to be an interesting week ahead on Wall Street.
US futures are pointing higher and there is a mega health insurance deal making headlines.
FOX BUSINESS ALERT: CVS to buy health insurance giant Aetna for $69 billion pic.twitter.com/m3zwCrh1UI
— FOX & friends (@foxandfriends) 4 December 2017
US drugstore giant CVS Health Corp (NYSE:CVS) has agreed to buy the managed heathcare group Aetna Inc (NYSE:AET) in what is being billed as the largest health insurance deal in history worth around US$69bn.
Including debt, the deal is reportedly worth US$77bn, and would drastically remap the health care industry.
Buying Aetna puts CVS in a better position to compete with other integrated health care providers such as UnitedHealthcare (UNH) and pharmacy benefits manager Optum, say commentators.
CVS Health Corp shares closed 1.93% down on Friday at US$75.12, and after hours added 0.23% to US$74.95 while Aetna shares closed Friday at US$181.31 - up 0.63% and are up 3.91% in pre-market.
Other companies in focus today may be Foundation Medicine Inc (NASDAQ:FMI), which shot up over 17% to US$62.60 on Friday after the key regulator - the FDA - approved the company’s FoundationOne CDx Diagnostic test for solid tumors.
In other news Nutanix Inc (NASDAQ:NTNX) shares surged almost 10% to stand at US$36.09 on Friday and after hours, shares are up 2.58% to US$367.99.
It came after the group reported a first quarter loss of 16 US cents, 10 US cents lower than analyst estimates.
Sales came in US$9mln, which were higher than estimates of US$275.6mln.
The firm issued better than expected second quarter earnings and sales guidance.